Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph early_phase_1
1
25%
Ph phase_2
2
50%
Ph phase_1
1
25%

Phase Distribution

2

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Terminated(2)
Other(2)

Detailed Status

Withdrawn2
unknown1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (25.0%)
Phase 11 (25.0%)
Phase 22 (50.0%)

Trials by Status

unknown125%
suspended125%
withdrawn250%

Recent Activity

0 active trials
Showing 4 of 4
withdrawnphase_2

Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study

NCT05227456
suspendedearly_phase_1

Body Composition and Sport Performance Among Young Female Soccer Players Using Subdermic Etonogestrel

NCT06775626
withdrawnphase_1

Antepartum Etonogestrel Contraceptive Implant Insertion at Term

NCT03656289
unknownphase_2

Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant

NCT03589040

Clinical Trials (4)

Showing 4 of 4 trials
NCT05227456Phase 2

Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study

Withdrawn
NCT06775626Early Phase 1

Body Composition and Sport Performance Among Young Female Soccer Players Using Subdermic Etonogestrel

Suspended
NCT03656289Phase 1

Antepartum Etonogestrel Contraceptive Implant Insertion at Term

Withdrawn
NCT03589040Phase 2

Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4